Health
FDA approves injectable treatment for HIV patients – OutSourcing-Pharma.com
The agency has given the thumbs up to ViiV’s once-a-month Cabenuva, the first FDA-approved injectable, complete regimen for adults diagnosed with HIV.
The US Food and Drug Administration (FDA) has approved Cabenuva (cabotegravir and rilpivirine) as a complete regimen intended to treat human immunodeficiency virus type 1 (HIV-1) infection in adults. The injectable drug is designed to replace a current antiretroviral regimen in patients who are virologically suppressed on a stable antiretroviral regimen, with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.
Cabenuva, a product from…
-
Noosa News24 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
Noosa News22 hours agoDeath of German shepherd Arnie prompts Brisbane community action to protect pets caught up in crime
-
General15 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News15 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial